Instytut Rozwoju I Badań Suplementówsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2025-04-02
Share capital
5,000.00 PLN
Registered address
ul. Niekłańska 35/1, 03-924 Warszawa, Poland
Electronic delivery address
AE:PL-31363-90458-DVJEV-19
Financials
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 1 day late).
- 202516/07/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 10.85kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD 2.35kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 8.19kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 3.61kMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Karol Sadłowski – Management Board Member
Paweł Marcin Ryćko – President of the Management Board
Mateusz Tupczyński – Management Board Member
Wiktor Mirosław Walczak – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Marcin Ryćkoage 42 | 25 | $337.66 | 25% |
Karol Sadłowskiage 30 | 25 | $337.66 | 25% |
Mateusz Tupczyńskiage 35 | 25 | $337.66 | 25% |
Wiktor Mirosław Walczakage 32 | 25 | $337.66 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-05-14.
89 1090 1014 0000 0001 6193 8861
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com |
FAQ
The main business activity of Instytut Rozwoju I Badań Suplementów focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on April 2, 2025.
The headquarters is located at: ul. Niekłańska 35, 03-924 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from March 27, 2025 to December 31, 2025.
In 2025, the company's revenue reached USD 10,854.
Yes, the company recorded a net profit of USD 2,351 in 2025.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 5,238 in 2025, representing 64% of all operating expenses.
Last updated: 2026-10-07